Skip to content

Effect of Chewing Gum in Hemodialysis Patients

Effect of Chewing Gum on Interdialytic Weight Gain, Thirst, Dry Mouth and Intradialytic Symptoms in Hemodialysis Patients: A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04142216
Enrollment
56
Registered
2019-10-29
Start date
2019-10-14
Completion date
2020-01-30
Last updated
2020-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chewing Gum, Hemodialysis

Keywords

Thirst, Weight gain

Brief summary

The aim of this prospective randomized controlled study was to investigate the effects of chewing gum on interdialytic weight gain, thirst, dry mouth and intradialytic symptoms in hemodialysis patients.

Detailed description

The prevalence of xerostomia varies high in patients with chronic hemodialysis (HD), and the decreased saliva flow rate due to various mechanisms is the main factor in its development. The significant decrease in saliva flow due to the atrophy and fibrosis of the salivary glands in HD patients is further affected by the restriction in fluid intake. The use of drugs such as antidepressants, antipsychotics, antihistamines, antihypertensives, aspirin, benzodiazepines, opioids and proton pump inhibitors also leads to hyposalivation and xerostomia. Thirst is common in chronic HD patients due to both volumetric and osmometric causes but the primary mechanism is osmometric. The osmolarity of the extracellular fluid increases with the dietary salt and the hypothalamus is stimulated by the shrinkage of the osmoreceptor cells, leading to the desire to ingest liquids. Volumetric thirst develops secondary to water and salt loss and the resultant stimulation of cardiac baroreceptors, with the cardiac return volume decreasing gradually towards the end of the HD session. Increased interdialytic weight in HD patients causes increased risk of death due to cerebrovascular events and cardiovascular diseases and leads to an increase in morbidity and mortality together with a deterioration of the patient's quality of life. Interdialytic weight gain (IWG) causes incompliance with fluid control as a result of the secondary excessive consumption of liquid and food and is an important condition.

Interventions

DIETARY_SUPPLEMENTChewing Gum

The patients will chew one piece of regular chewing gum six times in a day and feeling of thirst for ten minutes for three months.

Sponsors

Istanbul Demiroglu Bilim University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * On maintenance hemodialysis three times per week for four hours per session * Receiving hemodialysis therapy for a least six moths at the time of the study * Able to communicate in Turkish * Willing to participate to the study

Exclusion criteria

* 18 years of age younger * Absence of psychiatric disorders that cause cognitive dysfunction, such as Alzheimer's disease or chronic psychosis. * The patient who took chemotherapy and radiotherapy * Have salivary gland infection and dementia * Oral and / or dental diseases to prevent chewing gum * Unwilling to to participate to the study

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline Intradialytic Weight Gainup to 12 weeksInterdialytic weight gain was defined as the difference between the predialytic weight and weight at the end of the previous dialysis session
Change From Baseline Feeling of Thirst at Three MonthsAt the end of the 1st, 6th, 12th week (3 hemodialysis sessions are done every week)It will be assessed three times at the end of the dialysis session with Visual Analogue. Thirst intensity measured on a Visual Analog Scale with scores ranging from 0 - 10. Thirst increases as the score increases. The high point describes bad outcome.
Change From Baseline Dry Mouth at Three MonthsAt the end of the 1st, 6th, 12th week (3 hemodialysis sessions are done every week)It will be assessed three times at the end of the dialysis session with Visual Analogue Scale. Visual Analogue Scale ranging from 0 (no dry mouth) to 10 (worst dry mouth). Dry mouth increases the score increases. The high point describes bad outcome.
Change From Baseline Intradialytic Symptoms at Three MonthsAt the end of the 1st and 12th week (3 hemodialysis sessions are done every week)It will be assessed with Dialysis Symptom Index. Using this scoring system, the minimum possible total severity score was 0 if none of the 30 symptoms was present and the maximum potential. Score was 150 if all of the 30 symptoms were reported and rated as very much bothersome. The minimum value is 0 and the maximum value is 150.

Secondary

MeasureTime frameDescription
Change From Baseline Fluid Control at Three MonthsAt the end of the 1st and 12th week (3 hemodialysis sessions are done every week)It will be assessed with Fluid Control Scale in Hemodialysis Patients. the scale had 24 items and three subdimensions,namely, knowledge, behavior, and attitude. The lowest score obtained from the scale was 24 and the highest score was 72, and the higher the score, the greater the compliance of the patients with fluid control.
Change From Baseline Depression at Three MonthsAt the end of the 1st and 12th week (3 hemodialysis sessions are done every week)It will be assessed with Hospital Anxiety and Depression Scale. This scale, which has a two-factor structure is comprised of 14 items. Seven of these items assess the anxiety status and the remaining seven assess depression. Each item is scored on a four-point scale. Total score ranges between 0 and 21 for anxiety and depression. Scores between 0 and 7 indicate normal emotional status.
Change From Baseline Anxiety at Three MonthsAt the end of the 1st and 12th week (3 hemodialysis sessions are done every week)It will be assessed with Hospital Anxiety and Depression Scale. This scale, which has a two-factor structure is comprised of 14 items. Seven of these items assess the anxiety status and the remaining seven assess depression. Each item is scored on a four-point scale. Total score ranges between 0 and 21 for anxiety and depression. Scores between 0 and 7 indicate normal emotional status.

Countries

Turkey (Türkiye)

Participant flow

Recruitment details

Recruitment period: The assignment of patients to groups has began on October 14, 2019. It lasted on November 1, 2019.

Pre-assignment details

in chewing group: one person reject to join to the study. one person chewing clove.

Participants by arm

ArmCount
Chewing Gum Group
The patients will be asked to chew on a regular chewing gum for three months. Chewing Gum: The patients will chew one piece of regular chewing gum six times in a day and feeling of thirst for ten minutes for three months.
22
Control Group
The patients will not chewing gum during three months.
22
Total44

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath31
Overall StudyHospitalization02
Overall StudyReferral to another hemodialysis unit32
Overall StudyUse of clove01

Baseline characteristics

CharacteristicChewing Gum GroupControl GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
22 Participants22 Participants44 Participants
Age, Continuous61.72 years
STANDARD_DEVIATION 15.21
61.40 years
STANDARD_DEVIATION 16.64
61.56 years
STANDARD_DEVIATION 15.76
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
14 Participants8 Participants22 Participants
Sex: Female, Male
Male
8 Participants14 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
3 / 281 / 28
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Change From Baseline Dry Mouth at Three Months

It will be assessed three times at the end of the dialysis session with Visual Analogue Scale. Visual Analogue Scale ranging from 0 (no dry mouth) to 10 (worst dry mouth). Dry mouth increases the score increases. The high point describes bad outcome.

Time frame: At the end of the 1st, 6th, 12th week (3 hemodialysis sessions are done every week)

ArmMeasureValue (MEAN)Dispersion
Control GroupChange From Baseline Dry Mouth at Three Months5.04 units on a scaleStandard Deviation 2.76
Chewing Gum GroupChange From Baseline Dry Mouth at Three Months1.72 units on a scaleStandard Deviation 2.07
Primary

Change From Baseline Dry Mouth at Three Months

It will be assessed two times at the end of the dialysis session with sample of saliva. Saliva flow rate/minute will be measured. Saliva flow rate/minute is presented with ml.

Time frame: At the end of the 1st and 12th week (3 hemodialysis sessions are done every week)

ArmMeasureValue (MEAN)Dispersion
Control GroupChange From Baseline Dry Mouth at Three Months5.04 ml/minuteStandard Deviation 2.76
Chewing Gum GroupChange From Baseline Dry Mouth at Three Months1.72 ml/minuteStandard Deviation 2.07
Primary

Change From Baseline Feeling of Thirst at Three Months

It will be assessed three times at the end of the dialysis session with Visual Analogue. Thirst intensity measured on a Visual Analog Scale with scores ranging from 0 - 10. Thirst increases as the score increases. The high point describes bad outcome.

Time frame: At the end of the 1st, 6th, 12th week (3 hemodialysis sessions are done every week)

ArmMeasureValue (MEAN)Dispersion
Control GroupChange From Baseline Feeling of Thirst at Three Months5.04 score on a scaleStandard Deviation 2.76
Chewing Gum GroupChange From Baseline Feeling of Thirst at Three Months1.72 score on a scaleStandard Deviation 2.07
Primary

Change From Baseline Intradialytic Symptoms at Three Months

It will be assessed with Dialysis Symptom Index. Using this scoring system, the minimum possible total severity score was 0 if none of the 30 symptoms was present and the maximum potential. Score was 150 if all of the 30 symptoms were reported and rated as very much bothersome. The minimum value is 0 and the maximum value is 150.

Time frame: At the end of the 1st and 12th week (3 hemodialysis sessions are done every week)

ArmMeasureValue (MEAN)Dispersion
Control GroupChange From Baseline Intradialytic Symptoms at Three Months19.13 score on a scaleStandard Deviation 13.71
Chewing Gum GroupChange From Baseline Intradialytic Symptoms at Three Months19.18 score on a scaleStandard Deviation 15.27
Primary

Change From Baseline Intradialytic Weight Gain

Interdialytic weight gain was defined as the difference between the predialytic weight and weight at the end of the previous dialysis session

Time frame: up to 12 weeks

ArmMeasureValue (MEAN)Dispersion
Control GroupChange From Baseline Intradialytic Weight Gain2.53 kgStandard Deviation 0.8
Chewing Gum GroupChange From Baseline Intradialytic Weight Gain2.44 kgStandard Deviation 0.95
Secondary

Change From Baseline Anxiety at Three Months

It will be assessed with Hospital Anxiety and Depression Scale. This scale, which has a two-factor structure is comprised of 14 items. Seven of these items assess the anxiety status and the remaining seven assess depression. Each item is scored on a four-point scale. Total score ranges between 0 and 21 for anxiety and depression. Scores between 0 and 7 indicate normal emotional status.

Time frame: At the end of the 1st and 12th week (3 hemodialysis sessions are done every week)

ArmMeasureValue (MEAN)Dispersion
Control GroupChange From Baseline Anxiety at Three Months8.18 score on a scaleStandard Deviation 5.5
Chewing Gum GroupChange From Baseline Anxiety at Three Months8.40 score on a scaleStandard Deviation 5.71
Secondary

Change From Baseline Depression at Three Months

It will be assessed with Hospital Anxiety and Depression Scale. This scale, which has a two-factor structure is comprised of 14 items. Seven of these items assess the anxiety status and the remaining seven assess depression. Each item is scored on a four-point scale. Total score ranges between 0 and 21 for anxiety and depression. Scores between 0 and 7 indicate normal emotional status.

Time frame: At the end of the 1st and 12th week (3 hemodialysis sessions are done every week)

ArmMeasureValue (MEAN)Dispersion
Control GroupChange From Baseline Depression at Three Months8.63 score on a scaleStandard Deviation 4.9
Chewing Gum GroupChange From Baseline Depression at Three Months8.13 score on a scaleStandard Deviation 4.31
Secondary

Change From Baseline Fluid Control at Three Months

It will be assessed with Fluid Control Scale in Hemodialysis Patients. the scale had 24 items and three subdimensions,namely, knowledge, behavior, and attitude. The lowest score obtained from the scale was 24 and the highest score was 72, and the higher the score, the greater the compliance of the patients with fluid control.

Time frame: At the end of the 1st and 12th week (3 hemodialysis sessions are done every week)

ArmMeasureValue (MEAN)Dispersion
Control GroupChange From Baseline Fluid Control at Three Months53.95 score on a scaleStandard Deviation 6.06
Chewing Gum GroupChange From Baseline Fluid Control at Three Months58.04 score on a scaleStandard Deviation 4.82

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026